Indacaterol/glycopyrrolate

Indacaterol/glycopyrrolate
Combination of
Indacaterol Ultra-long-acting beta-adrenoceptor agonist
Glycopyrronium bromide Muscarinic anticholinergic
Clinical data
Trade names Ultibro Breezhaler
Pregnancy
category
Routes of
administration
Inhalation only
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only)
  • ℞ (Prescription only)
Identifiers
CAS Number 444313-53-5 YesY
ATC code R03AL04 (WHO)
PubChem CID 11564052

Indacaterol/glycopyrrolate (trade name Ultibro Breezhaler) is a combination drug consisting of the following two active ingreditents:

Indacaterol maleate/glycopyrronium bromide is used as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).[2]

References

  1. Cazzola M, Matera MG, Lötvall J (July 2005). "Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease". Expert Opin Investig Drugs 14 (7): 775–83. doi:10.1517/13543784.14.7.775. PMID 16022567.
  2. "Ultibro Breezhaler". medicines.org.uk. DataPharm. 2015-02-03. Retrieved 2015-02-09.
This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.